IDH1 and glioblastoma: With the advent of small molecules targeting RNA and RNA-binding proteins (RBPs) in the clinic16,17, targeting RNAs and RBPs could be the next frontier in targeting GAM infiltration and treating IDH-wild-type glioblastoma.